Aadi Bioscience Announces Leadership Transition

LOS ANGELES, March 3, 2023 -- (Healthcare Sales & Marketing Network) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers with alterations in mTOR pathway gene... Biopharmaceuticals, Oncology, Personnel Aadi Bioscience, FYARRO, mTOR pathway, PEComa
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news